Design Therapeutics, Inc.

Q4 2022 13F Holders

Symbol: DSGN
CUSIP: 25056L103
Type: Equity
Class: COM
Num filings: 96
Total reported value, excl. options: $445 M

Compare 2022 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type